Patrick Cohen
0009-0008-1187-1123
Sanofi SA
2 papers found
Refreshing results…
Reply to Y. Yoshitomi et al
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
Missing publications? Search for publications with a matching author name.